Eric Goosby

Goosby at a Press Conference at the United Nations Office in Geneva, December 11, 2009

In 1991, Goosby began his government career as director of HIV Services at the Health Resources and Services Administration, in the United States Department of Health and Human Services. In this position, he administered the newly-authorized Ryan White CARE Act, overseeing the distribution of federal funds and the planning of services in 25 AIDS epicenters, as well as in all 50 states and U.S. territories. In 1994, Goosby became director of the Office of HIV/AIDS Policy in the United States Department of Health and Human Services, where he advised on the federal HIV/AIDS budget and worked with Congress on all AIDS-related issues.

In 1995, Goosby created and convened the DHHS Panel on Clinical Practices for the Treatment of HIV Infections. This panel defined how to use protease inhibitors in conjunction with already existing antiretrovirals, later expanding its work to address standards of care for antiretroviral use for pediatric patients and pregnant women. Goosby has remained actively involved in this panel, now known the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, which is widely recognized as defining the standard of care for HIV/AIDS treatment in the United States.

In 1997, Goosby also served as interim director of the Office of National AIDS Policy at the White House, reporting directly to the President as his senior advisor on HIV-related issues. Goosby's office was responsible for guiding the implementation of this initiative at HHS over the next three years. Goosby's office also coordinated scientific reviews of needle exchange as a public health intervention. In 2000, Goosby served as acting deputy director of the National AIDS Policy Office in the White House, while continuing to work as director of HIV/AIDS policy at the Department of Health and Human Services.[8]

After leaving government service, Goosby was CEO and Chief Medical Officer of Pangaea Global AIDS Foundation from 2001 to 2009. He was also a Professor of Clinical Medicine at the University of California, San Francisco and a clinical provider for the 360 Men of Color Program.[9]

While with Pangaea, Goosby played a key role in the development and/or implementation of HIV/AIDS national treatment scale-up plans in Rwanda, South Africa, China, and Ukraine. During this time, Goosby developed extensive international experience in the development of treatment guidelines for use of antiretroviral therapies, clinical mentoring and training of health professionals, and the design and implementation of local models of care for HIV/AIDS, focusing his expertise on the scale-up of sustainable HIV/AIDS treatment capacity, including the delivery of HIV antiretroviral drugs, within existing healthcare systems.[8]

On January 20, 2015, United Nations Secretary-General Ban Ki-moon appointed Goosby as his new Special Envoy on Tuberculosis. In this capacity, Goosby will work towards boosting the profile of the fight against TB and promoting the adoption, financing and implementation of the World Health Organization’s global End TB Strategy after 2015.[10]

Goosby has served on the board of directors of the Clinton Foundation since 2013.[11]

On June 23, 2009, Goosby was sworn in as the United States Global AIDS Coordinator, heading up the President's Emergency Plan for AIDS Relief (PEPFAR). At the time of his swearing in, Goosby stated that his top priorities included:[12]

• intensifying the focus on HIV prevention
• pursuing strong country partnerships
• ensuring that HIV/AIDS initiatives are country owned and coordinated
• furthering the coordination of multilateral engagement
• strengthening health systems through programs and country-driven planning
• taking effective interventions to scale to achieve population-level health outcomes